Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity

摘要

The invention provides a compound of formula (I):; or tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the various substituents are as defined in the claims.;Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds.